Clinical Trial Update: Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients [Phase 3]

View source ↗

Summary

A Phase 3 pilot trial evaluating metabolism and weight changes in epilepsy patients treated with topiramate has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Epilepsy
• Partial Epilepsy
• Seizures

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy, Epilepsies, Partial | Phase 3 | Status: COMPLETED